Trimetazidine Di HCI
-
API Product :
Trimetazidine Di HCI
-
CEP :
-
-
WCC :
?
-
Therapeutic Use :
Cardiac therapy; Cerebral and peripheral vasotherapeutics
-
Originator :
Servier
-
CAS No. :
5011-34-7
-
Trade Name. :
Vastarel
-
Molecular Weight :
266.336 g/mol
-
Molecular Formula :
C14H22N2O3
Application
Trimetazidine is a drug for angina pectoris sold under many brand names. ... Trimetazidine is an anti-ischemic (anti-anginal) metabolic agent, which improves myocardial glucose utilization through inhibition of fatty acid metabolism, also known as fatty acid oxidation inhibitor.
General Description
Trimetazidine is a drug for angina pectoris sold under many brand names.[1] Trimetazidine is described as the first cytoprotective anti-ischemic agent developed and marketed by Laboratoires Servier (France). Trimetazidine is an anti-ischemic (anti-anginal) metabolic agent, which improves myocardial glucose utilization through inhibition of fatty acid metabolism, also known as fatty acid oxidation inhibitor.